Company Search:
Advanced Search
Sponsored Links
Evotec AG - ADR Company Snapshot
Evotec AG - ADR operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Evotec AG - ADR with three other companies in this sector in the United States: Mannkind Corporation (2016 sales of $174.76 million of which 100% was Therapeutic Products), FibroGen Inc ($179.58 million ), and Eagle Pharmaceuticals, Inc ($189.48 million ).

Sales Analysis. During the year ended December of 2016, sales at Evotec AG - ADR were $181.57 million. This is an increase of 28.9% versus 2015, when the company's sales were $140.82 million. This was the fifth consecutive year of sales increases at Evotec AG - ADR (and since 2011, sales have increased a total of 62%). Sales of Evt Execute saw an increase of 29.9% in 2016, from $117.16 million to $152.15 million.
  Stock Performance Chart for Evotec AG - ADR
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 34.70
(Figures in U.S. Dollars)
1 Week 2.7%   13 Weeks 9.3%  
4 Weeks -29.0%   52 Weeks 108.9%  
Evotec AG - ADR Key Data:
  Ticker: EVTCY Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 181,571,311
(Year Ending Jan 2017).
Employees: 1,238
  Currency: U.S. Dollars Market Cap: 2,555,071,294
  Fiscal Yr Ends: December Shares Outstanding: 73,633,179
  Share Type: Stammaktie Closely Held Shares: 6,700,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.